Switglim MP 1mg/500mg/15mg Tablet SR
Marketer
Akumentis Healthcare Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Switglim MP 1mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication managing blood glucose. This therapy, alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin effectiveness, reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the usual regimen. Never double the dose. Excessive dosage can cause hypoglycemia. Concurrent use with other antidiabetic medications, alcohol, or skipped meals may precipitate hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function assessment precedes treatment initiation. Limit alcohol consumption as it can intensify side effects.
Uses of Switglim MP 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Switglim MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The Switglim MP 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Switglim MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Switglim MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Switglim MP 1mg/500mg/15mg Extended-Release tablets should be taken with a meal.
How Switglim MP 1mg/500mg/15mg Tablet SR works:
Switglim MP 1mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Switglim MP 1mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Switglim MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Switglim MP 1mg/500mg/15mg Tablet SR is likely unsafe. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when prescribing Switglim MP 1mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not receive this medication. Close monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Switglim MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Switglim MP 1mg/500mg/15mg SR tablets are contraindicated in patients experiencing severe hepatic dysfunction.
What if you forget to take Switglim MP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Switglim MP 1mg/500mg/15mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Switglim MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently